Also known as Serzone
Nefazodone (Serzone, Nefadar) is an antidepressant marketed by Bristol-Myers Squibb. Its sale was discontinued in 2003 in some countries due to the rare incidence of hepatotoxicity (liver damage), which could lead to the need for a liver transplant, or even death. The incidence of severe liver damage is approximately 1 in every 250,000 to 300,000 patient-years. On June 14, 2004, Bristol-Myers Squibb discontinued the sale of Serzone in the United States and Canada. Several generic formulations of nefazodone are still available.Source: Wikipedia
Estimated Total Cost: $38.84 for an average of 28 days supply
Patients are most commonly prescribed nefazodone to treat depression, bipolar disorder, rabies, and pick disease.